New Delhi: Corporate Hospital chain Global Health Limited listed with the name Medanta in Q4 FY25 reported a total income of ₹954.2 crore with a net profit of ₹101.4 crore.
During the quarter the Hospital revenue from operations went up 15.2 per cent to ₹931 crore while the net profit reported a year-on-year (YoY) decline of 20.4 per cent against the corresponding quarter profit of ₹127 crore.
On sequential basis Profit After Tax for Q4 profit reflects a sharp decline against the previous quarter figure of ₹142 crore.
In Q4 profit was impacted due to non-recurring exceptional expense items of ₹49.9 crore arising due to merger of MHPL with GHL, the Hospital said in a release.
Additionally, while the hospital’s bed occupancy rate increased by 12.3 per cent to 61.3 per cent, ARPOB (Average Revenue Per Occupied Bed) grew marginally by 0.9 per cent YoY to ₹63,629.
For the full financial year FY24-25 Medanta revenue from operations went up 12.7 per cent to ₹3,692 crore while the net profit expanded marginally by 0.7 per cent to ₹481 crore, up against ₹478 crore recorded in the previous fiscal.
Commenting over the group future plans Pankaj Sahni, Group CEO and Director said, “The three greenfield projects announced by the hospital in the high-growth markets of Mumbai, Pitampura, and Guwahati are expected to be operational in the next three to four years, will not only expand our footprint but also meaningfully diversify our presence across the country.”
During the fiscal Medanta has added 219 new beds across its network— 49 beds at Gurugram, 58 at Lucknow and 112 beds at Patna hospital.
Recently the hospital board has approved a ₹500 crore super speciality greenfield project in Guwahati and its Noida project is expected to be operational by September this year.>
